04:59 PM EDT, 07/31/2024 (MT Newswires) -- Robert I Blum, Director, President & CEO, on July 30, 2024, sold 11,500 shares in Cytokinetics ( CYTK ) for $684,135. Following the Form 4 filing with the SEC, Blum has control over a total of 403,578 shares of the company, with 399,412 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224021230/xslF345X03/form4.xml

Price: 58.50, Change: -0.51, Percent Change: -0.86